Clinical Trial

Pilot Study of the ARTUS® Artificial Urinary Sphincter on Women

Study acronym: SPHIN-X
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The subjects will be implanted with the ARTUS® medical device and then be followed up to 2 years post-implantation, with the primary endpoints measured at 3-month post-implantation. Safety and Clinical performance outcomes will be measured for each subject at baseline (before implantation) and post-implantation.
Trial Details
NCT Number NCT07641218
Lead Sponsor Myopowers Medical Technologies France SAS
Conditions Urinary Incontinence , Stress
Enrollment 6 participants
Start Date 2026-06-30
Primary Completion 2027-03-30 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-11